Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2022)

Keros Therapeutics' Interest Coverage Ratio history spans 4 years, with the latest figure at 24126.0 for Q1 2022.

  • For Q1 2022, Interest Coverage Ratio fell 53.0% year-over-year to 24126.0; the TTM value through Dec 2022 reached 114790.0, down 714.5%, while the annual FY2022 figure was 114790.0, 714.5% down from the prior year.
  • Interest Coverage Ratio reached 24126.0 in Q1 2022 per KROS's latest filing, down from 4866.0 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 775.33 in Q3 2019 to a low of 24126.0 in Q1 2022.
  • Average Interest Coverage Ratio over 4 years is 9954.99, with a median of 8444.0 recorded in 2020.
  • Peak YoY movement for Interest Coverage Ratio: tumbled 723.39% in 2020, then soared 63.39% in 2021.
  • A 4-year view of Interest Coverage Ratio shows it stood at 775.33 in 2019, then crashed by 1614.23% to 13291.0 in 2020, then skyrocketed by 63.39% to 4866.0 in 2021, then plummeted by 395.81% to 24126.0 in 2022.
  • Per Business Quant, the three most recent readings for KROS's Interest Coverage Ratio are 24126.0 (Q1 2022), 4866.0 (Q4 2021), and 20197.0 (Q3 2021).